| Officer | Age | In this role | Joined | Pay | Source |
|---|---|---|---|---|---|
|
Geert R. Kersten
Also a director
Director, Chief Executive Officer and Treasurer
|
67 | Not stated | 1987 | Not reported | |
|
Patricia B. Prichep
Chief Financial Officer
Title from the Form 4 dated Sep 30, 2026
|
74 | Not stated | 1992 | Not reported | |
|
Eyal Talor
Chief Scientific Officer
|
69 |
Since 2009
17 years
|
1993 | Not reported | |
|
John Cipriano
Senior Vice President of Regulatory Affairs
|
83 |
Since 2009
17 years
|
Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchase of 32,116 restricted shares of common stock at an aggregate market value of approximately $220,000
Purchase of 1,933 restricted shares of common stock at an aggregate market value of approximately $81,000
Loading...
